+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Clonixin"

Clonixin (CAS 17737-65-4) Global Market Research Report 2024 - Product Thumbnail Image

Clonixin (CAS 17737-65-4) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Clonixin is an analgesic drug used to treat mild to moderate pain. It is a non-steroidal anti-inflammatory drug (NSAID) and is available in both oral and injectable forms. It is commonly used to treat headaches, muscle pain, and menstrual cramps. It is also used to reduce fever and inflammation. Clonixin works by blocking the production of certain chemicals in the body that cause pain and inflammation. Clonixin is available in many countries around the world, including the United States, Canada, Australia, and the United Kingdom. It is available in both generic and brand-name forms. It is typically sold in tablet, capsule, and liquid forms. The Clonixin market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Other companies include Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more